These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26136378)

  • 1. Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis.
    Česnek M; Jansa P; Šmídková M; Mertlíková-Kaiserová H; Dračínský M; Brust TF; Pávek P; Trejtnar F; Watts VJ; Janeba Z
    ChemMedChem; 2015 Aug; 10(8):1351-64. PubMed ID: 26136378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleobase Modified Adefovir (PMEA) Analogues as Potent and Selective Inhibitors of Adenylate Cyclases from Bordetella pertussis and Bacillus anthracis.
    Česnek M; Skácel J; Jansa P; Dračínský M; Šmídková M; Mertlíková-Kaiserová H; Soto-Velasquez MP; Watts VJ; Janeba Z
    ChemMedChem; 2018 Sep; 13(17):1779-1796. PubMed ID: 29968968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amidate prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine as inhibitors of adenylate cyclase toxin from Bordetella pertussis.
    Šmídková M; Dvoráková A; Tloust'ová E; Česnek M; Janeba Z; Mertlíková-Kaiserová H
    Antimicrob Agents Chemother; 2014; 58(2):664-71. PubMed ID: 24145524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases.
    Břehová P; Chaloupecká E; Česnek M; Skácel J; Dračínský M; Tloušťová E; Mertlíková-Kaiserová H; Soto-Velasquez MP; Watts VJ; Janeba Z
    Eur J Med Chem; 2021 Oct; 222():113581. PubMed ID: 34102377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halogen-Dance-Based Synthesis of Phosphonomethoxyethyl (PME) Substituted 2-Aminothiazoles as Potent Inhibitors of Bacterial Adenylate Cyclases.
    Česnek M; Šafránek M; Dračínský M; Tloušťová E; Mertlíková-Kaiserová H; Hayes MP; Watts VJ; Janeba Z
    ChemMedChem; 2022 Jan; 17(1):e202100568. PubMed ID: 34636150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of α-Branched Acyclic Nucleoside Phosphonates as Potential Inhibitors of Bacterial Adenylate Cyclases.
    Frydrych J; Skácel J; Šmídková M; Mertlíková-Kaiserová H; Dračínský M; Gnanasekaran R; Lepšík M; Soto-Velasquez M; Watts VJ; Janeba Z
    ChemMedChem; 2018 Jan; 13(2):199-206. PubMed ID: 29235265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, anti-HBV activity and renal cell toxicity evaluation of mixed phosphonate prodrugs of adefovir.
    Fu XZ; Ou Y; Pei JY; Liu Y; Li J; Zhou W; Lan YY; Wang AM; Wang YL
    Eur J Med Chem; 2012 Mar; 49():211-8. PubMed ID: 22305613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases.
    Břehová P; Šmídková M; Skácel J; Dračínský M; Mertlíková-Kaiserová H; Velasquez MP; Watts VJ; Janeba Z
    ChemMedChem; 2016 Nov; 11(22):2534-2546. PubMed ID: 27775243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel bis(L-amino acid) ester prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) with improved anti-HBV activity.
    Fu X; Jiang S; Li C; Xin J; Yang Y; Ji R
    Bioorg Med Chem Lett; 2007 Jan; 17(2):465-70. PubMed ID: 17074481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of pivoxil esters of antiviral acyclic nucleoside phosphonates: adefovir dipivoxil versus adefovir.
    Zídek Z; Kmonícková E; Holý A
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):315-9. PubMed ID: 16601779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability.
    Benzaria S; Pélicano H; Johnson R; Maury G; Imbach JL; Aubertin AM; Obert G; Gosselin G
    J Med Chem; 1996 Dec; 39(25):4958-65. PubMed ID: 8960556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir.
    Kraina P; Česnek M; Tloušťová E; Mertlíková-Kaiserová H; Fulton CJ; Davidson EK; Smith BP; Watts VJ; Janeba Z
    Bioorg Med Chem; 2023 Nov; 95():117508. PubMed ID: 37931521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel oxazaphosphorine prodrugs of 9-(2-phosphonomethoxyethyl)adenine (PMEA, adefovir) as potent HBV inhibitors.
    Lu P; Liu J; Wang Y; Chen X; Yang Y; Ji R
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6918-21. PubMed ID: 19889538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Design, synthesis and anti-hBV evaluation of adefovir mono-L-amino acid ester, mono non-steroidal anti-inflammatory drugs carboxylic ester prodrugs].
    Fu XZ; Wang YL; Lan YY; Wang AM; Ou Y; Luo C; Li Y
    Yao Xue Xue Bao; 2010 Aug; 45(8):1017-24. PubMed ID: 21351588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, oral bioavailability determination, and in vitro evaluation of prodrugs of the antiviral agent 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).
    Starrett JE; Tortolani DR; Russell J; Hitchcock MJ; Whiterock V; Martin JC; Mansuri MM
    J Med Chem; 1994 Jun; 37(12):1857-64. PubMed ID: 8021925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
    Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
    Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordination Chemistry of Nucleotides and Antivirally Active Acyclic Nucleoside Phosphonates, including Mechanistic Considerations.
    Sigel A; Sigel H; Sigel RKO
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35565975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PMPA and PMEA prodrugs for the treatment of HIV infections and human papillomavirus (HPV) associated neoplasia and cancer.
    Pertusati F; Hinsinger K; Flynn ÁS; Powell N; Tristram A; Balzarini J; McGuigan C
    Eur J Med Chem; 2014 May; 78():259-68. PubMed ID: 24686012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and metabolism of selected prodrugs of PMEA in rats.
    Shaw JP; Louie MS; Krishnamurthy VV; Arimilli MN; Jones RJ; Bidgood AM; Lee WA; Cundy KC
    Drug Metab Dispos; 1997 Mar; 25(3):362-6. PubMed ID: 9172955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cycloSal-PMEA and cycloAmb-PMEA: potentially new phosphonate prodrugs based on the cycloSal-pronucleotide approach.
    Meier C; Görbig U; Müller C; Balzarini J
    J Med Chem; 2005 Dec; 48(25):8079-86. PubMed ID: 16335932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.